Skip to main content
. Author manuscript; available in PMC: 2007 Nov 9.
Published in final edited form as: Pharm Res. 2006 Aug;23(8):1641–1658. doi: 10.1007/s11095-006-9024-3

Table I.

Nonsteroidal Antiandrogens

Chemotype General chemical
structure		 Lead compound Company
(stage of development)
Aryl propionamide analogs graphic file with name nihms-32219-t0004.jpg Bicalutamide graphic file with name nihms-32219-t0005.jpg AstraZeneca Pharmaceuticals LP Casodex™
Flutamide graphic file with name nihms-32219-t0006.jpg Schering Corp. Eulexin™
Hydantoin analogs graphic file with name nihms-32219-t0007.jpg Nilutamide graphic file with name nihms-32219-t0008.jpg Aventis Nilandron™
RU58642 graphic file with name nihms-32219-t0009.jpg Roussel-Uclaf SA Preclinical
RU58841 graphic file with name nihms-32219-t0010.jpg Roussel-Uclaf SA Preclinical
BMS-25 graphic file with name nihms-32219-t0011.jpg graphic file with name nihms-32219-t0012.jpg Preclinical
BMS-7 graphic file with name nihms-32219-t0013.jpg
BMS-9 graphic file with name nihms-32219-t0014.jpg
Quinoline analogs (Tri-cyclic) graphic file with name nihms-32219-t0015.jpg LG120907 graphic file with name nihms-32219-t0016.jpg Ligand Pharmaceuticals Preclinical
LG105 graphic file with name nihms-32219-t0017.jpg Ligand Pharmaceuticals Preclinical